Dyan J Summers, DNP, MPH Registered Nurse - Home Health Medicare: Medicare Enrolled Practice Location: 9900 Bren Road East, Mail Route Mn 008-b213, Minnentonka, MN 55343 Phone: 646-319-3707 |
News Archive
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests. Currently, seasonal flu vaccines are designed to induce high levels of protective antibodies against hemagglutinin (HA), a protein found on the surface of the influenza virus that enables the virus to enter a human cell and initiate infection.
Researchers from Boston University School of Medicine have developed and tested a new computational tool, Candidate Driver Analysis, which will search for combinations of factors that are likely to cause a specific disease.
Hepatitis G virus was identified in 1995. Some little research was carried out on the virus and the US Food and Drug Administration (FDA) declared it a non-harmful virus in 1997. Researchers in Saudi Arabia, writing in the International Journal of Immunological Studies present evidence to suggest that this may have been the wrong decision.
US-Australian drug discovery company, Novogen, today announced that its subsidiary joint venture company with Yale University, CanTx, Inc, has today received notification from the U.S. Food and Drug Administration that its chemotherapy candidate drug, Cantrixil, has been granted Orphan Drug Designation for ovarian cancer.
A new study conducted by the American Institute for Cancer Research (AICR) and the World Cancer Research Fund (WCRF) found that the daily intake of grains, such as those from whole-wheat bread or brown rice reduces the risk of colorectal cancer; the risk is expected to decrease with the increase in the amount of gains consumed.
› Verified 1 days ago